Key result
Novel NIRF macrophage tracers increase plaque-to-background signal up to ~70% in murine atherosclerosis.
Why the study?
Successful imaging of atherosclerosis is crucial for diagnosis and intervention, motivating the evaluation of macrophage-targeting fluorescent tracers for near-infrared fluorescence (NIRF) plaque detection.
Do the macrophage-targeting NIRF tracers TLR4-ZW800-1C and ferumoxytol-Alexa Fluor 750 increase fluorescence signal detection in atherosclerotic carotid plaques compared to control vessels in a diabetic atherosclerotic mouse model?
Do the macrophage-targeting NIRF tracers TLR4-ZW800-1C and ferumoxytol-Alexa Fluor 750 increase fluorescence signal detection in atherosclerotic carotid plaques compared to control vessels in a diabetic atherosclerotic mouse model?
Both TLR4-ZW800-1C and ferumoxytol-AF750 successfully localized to inflamed atherosclerotic carotid plaques in mice with high ex vivo signal-to-background ratios, supporting further evaluation via intravascular NIRF catheters in larger animal models.
Answers are grounded in this paper and cite their sources.
May support NIRF plaque imaging development; leaves open translation to intravascular use in larger models.
Successful imaging of atherosclerosis, one of the leading global causes of death, is crucial for diagnosis and intervention. Near-infrared fluorescence (NIRF) imaging has been widely adopted along with multimodal/hybrid imaging systems for plaque detection. We evaluate two macrophage-targeting fluorescent tracers for NIRF imaging (TLR4-ZW800-1C and Feraheme-Alexa Fluor 750) in an atherosclerotic murine cohort, where the left carotid artery (LCA) is ligated to cause stenosis, and the right carotid artery (RCA) is used as a control. Imaging performed on dissected tissues revealed that both tracers had high uptake in the diseased vessel compared to the control, which was readily visible even at short exposure times. In addition, ZW800-1C's renal clearance ability and Feraheme's FDA approval puts these two tracers in line with other NIRF tracers such as ICG. Continued investigation with these tracers using intravascular NIRF imaging and larger animal models is warranted for clinical translation.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2021) studied Carotid atherosclerosis (murine model) (n=14). Macrophage-targeting near-infrared fluorescence tracers (TLR4-ZW800-1C or ferumoxytol-Alexa Fluor 750 [FH-AF750]) vs. Intact right carotid artery (RCA) within the same animal serving as negative control was evaluated on Ex vivo near-infrared fluorescence signal-to-background ratio (SBR) at 100 ms exposure in the ligated left carotid artery (LCA) versus control right carotid artery (RCA). TLR4-ZW800-1C and FH-AF750 increased ex vivo NIRF signal-to-background ratio by 31% and 70%, respectively, in ligated atherosclerotic left vs control right carotid arteries.
Synapse has enriched 10 related papers. Consider them for comparative context: